Calcium-induced Folding of a Fragment of Calmodulin Composed of EF-hands 2 and 3
Overview
Affiliations
Calmodulin (CaM) is an EF-hand protein composed of two calcium (Ca(2+))-binding EF-hand motifs in its N-domain (EF-1 and EF-2) and two in its C-domain (EF-3 and EF-4). In this study, we examined the structure, dynamics, and Ca(2+)-binding properties of a fragment of CaM containing only EF-2 and EF-3 and the intervening linker sequence (CaM2/3). Based on NMR spectroscopic analyses, Ca(2+)-free CaM2/3 is predominantly unfolded, but upon binding Ca(2+), adopts a monomeric structure composed of two EF-hand motifs bridged by a short antiparallel beta-sheet. Despite having an "even-odd" pairing of EF-hands, the tertiary structure of CaM2/3 is similar to both the "odd-even" paired N- and C-domains of Ca(2+)-ligated CaM, with the conformationally flexible linker sequence adopting the role of an inter-EF-hand loop. However, unlike either CaM domain, CaM2/3 exhibits stepwise Ca(2+) binding with a K (d1) = 30 +/- 5 microM to EF-3, and a K (d2) > 1000 microM to EF-2. Binding of the first equivalent of Ca(2+) induces the cooperative folding of CaM2/3. In the case of native CaM, stacking interactions between four conserved aromatic residues help to hold the first and fourth helices of each EF-hand domain together, while the loop between EF-hands covalently tethers the second and third helices. In contrast, these aromatic residues lie along the second and third helices of CaM2/3, and thus are positioned adjacent to the loop between its "even-odd" paired EF-hands. This nonnative hydrophobic core packing may contribute to the weak Ca(2+) affinity exhibited by EF-2 in the context of CaM2/3.
Morris V, Richards E, Morris R, Dart C, Helassa N Cells. 2025; 14(3).
PMID: 39936944 PMC: 11816674. DOI: 10.3390/cells14030152.
Loh S, Anthony I, Gavor E, Lim X, Kini R, Mok Y Biology (Basel). 2024; 13(1).
PMID: 38248473 PMC: 10813304. DOI: 10.3390/biology13010042.
Mikolajczak K, Kuczynska A, Krajewski P, Kempa M, Witaszak N Cells. 2023; 12(13).
PMID: 37443719 PMC: 10340373. DOI: 10.3390/cells12131685.
Tumor Suppressor Candidate 2 (TUSC2): Discovery, Functions, and Cancer Therapy.
Arrigo A, Regua A, Najjar M, Lo H Cancers (Basel). 2023; 15(9).
PMID: 37173921 PMC: 10177220. DOI: 10.3390/cancers15092455.
Kayastha B, Kubo A, Burch-Konda J, Dohmen R, McCoy J, Rogers R Sci Rep. 2022; 12(1):8791.
PMID: 35614085 PMC: 9132961. DOI: 10.1038/s41598-022-12584-9.